These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20090473)
1. Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase. Wang Y; Moreira Mda C; Heringer-Walther S; Schultheiss HP; Siems WE; Wessel N; Walther T J Cardiovasc Pharmacol; 2010 Jan; 55(1):62-6. PubMed ID: 20090473 [TBL] [Abstract][Full Text] [Related]
2. Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies? Heringer-Walther S; Moreira Mda C; Wessel N; Wang Y; Ventura TM; Schultheiss HP; Walther T J Cardiovasc Pharmacol; 2006 Dec; 48(6):293-8. PubMed ID: 17204908 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation. Moreira Mda C; Heringer-Walther S; Wessel N; Moreira Ventura T; Wang Y; Schultheiss HP; Walther T Cardiology; 2008; 110(4):217-25. PubMed ID: 18073475 [TBL] [Abstract][Full Text] [Related]
4. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981 [TBL] [Abstract][Full Text] [Related]
5. Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP. Wang Y; Moreira Mda C; Heringer-Walther S; Ebermann L; Schultheiss HP; Wessel N; Siems WE; Walther T J Card Fail; 2010 Feb; 16(2):157-63. PubMed ID: 20142028 [TBL] [Abstract][Full Text] [Related]
6. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
7. Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides. Charles CJ; Prickett TC; Espiner EA; Rademaker MT; Richards AM; Yandle TG Peptides; 2006 Jan; 27(1):62-8. PubMed ID: 16095755 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides. Moreira Mda C; Wang Y; Heringer-Walther S; Wessel N; Walther T Congest Heart Fail; 2009; 15(2):75-81. PubMed ID: 19379453 [TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides and their therapeutic potential. Cho Y; Somer BG; Amatya A Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638 [TBL] [Abstract][Full Text] [Related]
12. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure. Bentzen H; Pedersen RS; Nyvad O; Pedersen EB Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537 [TBL] [Abstract][Full Text] [Related]
13. Relation of ANP and BNP to their N-terminal fragments in fetal circulation: evidence for enhanced neutral endopeptidase activity and resistance of BNP to neutral endopeptidase in the fetus. Walther T; Stepan H; Pankow K; Gembardt F; Faber R; Schultheiss HP; Siems WE BJOG; 2004 May; 111(5):452-5. PubMed ID: 15104609 [TBL] [Abstract][Full Text] [Related]
16. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507 [TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide levels in obese patients with advanced heart failure. Horwich TB; Hamilton MA; Fonarow GC J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669 [TBL] [Abstract][Full Text] [Related]
18. Comparison of NT-proCNP and CNP plasma levels in heart failure, diabetes and cirrhosis patients. Del Ry S; Cabiati M; Stefano T; Catapano G; Caselli C; Prescimone T; Passino C; Emdin M; Giannessi D Regul Pept; 2011 Jan; 166(1-3):15-20. PubMed ID: 20800621 [TBL] [Abstract][Full Text] [Related]
19. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508 [TBL] [Abstract][Full Text] [Related]
20. Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure. Del Ry S; Cabiati M; Lionetti V; Simioniuc A; Caselli C; Prescimone T; Emdin M; Giannessi D Peptides; 2009 Sep; 30(9):1710-3. PubMed ID: 19540894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]